Latest signals
All signals, newest first. Each row links to the source filing.
| Filing | Molecule | Signal | Plant | Stage | t / year | Source |
|---|---|---|---|---|---|---|
| Oct 2026 | 85 molecules in one filing | ↑ NEW PLANT | Nanoarray Biosciences Pvt. Ltd.Ahmedabad, Gujarat | Public hearing held | — | EIA executive summary, GPCB |
| Sep 2026 | Whole site | ↑ NEW PLANT | Arhanth Bio CDMO Pvt. Ltd.Surat, Gujarat | Public hearing held | +60 | Public hearing record, GPCB |
| Sep 2026 | Whole site | ↑ NEW AT SITE | Bhakti Pharmaceuticals Pvt. Ltd.Rajkot, Gujarat | Public hearing held | +240 | Public hearing record, GPCB |
| Sep 2026 | Whole site | ↑ NEW PLANT | Dr. Dalavai’s Laboratories Pvt. Ltd.Tirupati, Andhra Pradesh | Public hearing held | — | Public hearing list, APPCB |
| Jul 2026 | Whole site | ↑ NEW PLANT | Fenvitta Life Sciences LLPRajkot, Gujarat | Public hearing held | +781 | Public hearing record, GPCB |
| Jul 2026 | Denatonium chloride | ↑ NEW PLANT | Keshri Organics Pvt. Ltd.Anand, Gujarat | Public hearing held | — | Public hearing record, GPCB |
| Jul 2026 | Denatonium benzoate | ↑ NEW PLANT | Keshri Organics Pvt. Ltd.Anand, Gujarat | Public hearing held | — | Public hearing record, GPCB |
| Jul 2026 | Denatonium saccharide | ↑ NEW PLANT | Keshri Organics Pvt. Ltd.Anand, Gujarat | Public hearing held | — | Public hearing record, GPCB |
| Jul 2026 | Lidocaine | ↑ NEW PLANT | Keshri Organics Pvt. Ltd.Anand, Gujarat | Public hearing held | — | Public hearing record, GPCB |
| Jul 2026 | Whole site | ↑ NEW AT SITE | Lenient Lifecare Pvt. Ltd.Rajkot, Gujarat | Terms of reference issued | +600 | EIA executive summary, GPCB |
| Jun 2026 | Whole site | ↑ NEW PLANT | Atoll Pharma Pvt. Ltd.Mehsana, Gujarat | Public hearing held | +320 | Public hearing record, GPCB |
| Jun 2026 | Glatiramer acetate | ↑ NEW PLANT | Amneal Biopharma Synthesis Pvt. Ltd.Ahmedabad, Gujarat | Public hearing held | +1.2 | Public hearing record, GPCB |
| Jun 2026 | Whole site | ↑ NEW PLANT | Dwirayu Pharma Pvt. Ltd.Ahmedabad, Gujarat | Public hearing held | +246 | Public hearing record, GPCB |
| Apr 2026 | Rivaroxaban | ↑ NEW AT SITE | Besi Drugs Pvt. Ltd.Nashik, Maharashtra | Public hearing held | +6 | EIA executive summary, MPCB |
| Apr 2026 | Sitagliptin phosphate monohydrate | ↑ NEW AT SITE | Besi Drugs Pvt. Ltd.Nashik, Maharashtra | Public hearing held | +3 | EIA executive summary, MPCB |
| Apr 2026 | Linagliptin | ↑ NEW AT SITE | Besi Drugs Pvt. Ltd.Nashik, Maharashtra | Public hearing held | +3 | EIA executive summary, MPCB |
| Apr 2026 | Mefenamic acid | ↓ DROPPED | Besi Drugs Pvt. Ltd.Nashik, Maharashtra | Public hearing held | −40 | EIA executive summary, MPCB |
| Apr 2026 | Whole site | ↑ NEW PLANT | Apicon Pharma LLPVadodara, Gujarat | Public hearing held | +132 | Public hearing record, GPCB |
| Feb 2026 | Nirogacestat | ↑ NEW AT SITE | Sai Life Sciences Ltd.Bidar, Karnataka (Unit IV) | Clearance granted | +5 | Environmental clearance, SEIAA Karnataka |
| Feb 2026 | Ribavirin | ↓ DROPPED | Sai Life Sciences Ltd.Bidar, Karnataka (Unit IV) | Clearance granted | −1.2 | Environmental clearance, SEIAA Karnataka |
| Feb 2026 | Whole site | ↓ CLEARANCE SURRENDERED | Glenmark Pharmaceuticals Ltd.Aurangabad, Maharashtra | State authority agenda | — | 319th SEIAA agenda, Maharashtra |
| Jan 2026 | 16 molecules in one filing | ↑ CAPACITY UP | Fusion Health Care Pvt. Ltd.Kamareddy, Telangana | Public hearing held | — | EIA executive summary, TGPCB |
| Jan 2026 | 9 molecules in one filing | ↓ CAPACITY CUT | Fusion Health Care Pvt. Ltd.Kamareddy, Telangana | Public hearing held | — | EIA executive summary, TGPCB |
| Jan 2026 | 25 molecules in one filing | ↑ NEW AT SITE | Fusion Health Care Pvt. Ltd.Kamareddy, Telangana | Public hearing held | — | EIA executive summary, TGPCB |
| Dec 2025 | Whole site | ↑ NEW AT SITE | Alembic Pharmaceuticals Ltd.Vadodara, Gujarat | Public hearing held | +240 | Public hearing record, GPCB |
| Sep 2025 | Losartan potassium | ⇄ OWN INTERMEDIATES | IPCA Laboratories Ltd.Wardha, Maharashtra | Public hearing held | +3,480 | EIA executive summary, MPCB |
| Sep 2025 | Furosemide | ⇄ OWN INTERMEDIATES | IPCA Laboratories Ltd.Wardha, Maharashtra | Public hearing held | +1,200 | EIA executive summary, MPCB |
| Jun 2025 | Rivaroxaban | ↑ NEW PLANT | Juvenus DrugsVillupuram, Tamil Nadu | Terms of reference issued | +0.6 | Draft EIA executive summary, TNPCB |
| Jun 2025 | Gabapentin | ↑ NEW PLANT | Juvenus DrugsVillupuram, Tamil Nadu | Terms of reference issued | +12 | Draft EIA executive summary, TNPCB |
| Feb 2025 | Whole site | ↑ CAPACITY UP | Sterling Biotech Ltd.Vadodara, Gujarat | Public hearing held | +1,310 | Public hearing record, GPCB |
Monthly signal digest
New capacity, exits and integration moves in one email. Tell us which molecules you watch.